Viewing Study NCT03248492

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:41 PM
Ignite Modification Date: 2026-06-07 @ 1:47 AM
Study NCT ID: NCT03248492
Status: TERMINATED
Last Update Posted: 2025-06-26
First Post: 2017-08-10
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study of DS-8201a in Metastatic Breast Cancer Previously Treated With Trastuzumab Emtansine (T-DM1)
Sponsor: Daiichi Sankyo
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HER-2 positive breast cancer View
None Metastatic or Unresectable View
None Resistant or refractory to T-DM1 View
None DESTINY - Breast 01 View
None Trastuzumab deruxtecan View
None T-DXd View